[Pharmaceutical view of rifampicin (author's transl)].
D000818:Animals; D055598:Chemical Phenomena; D002621:Chemistry; D012321:DNA-Directed RNA Polymerases / Q000037:antagonists & inhibitors; D004285:Dogs; D006168:Guinea Pigs; D006801:Humans; D007918:Leprosy / Q000188:drug therapy; D012329:RNA, Bacterial; D011817:Rabbits; D051381:Rats; D012293:Rifampin / Q000009:adverse effects / Q000097:blood / Q000302:isolation & purification / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D013045:Species Specificity
D012329:RNA, Bacterial; D012321:DNA-Directed RNA Polymerases; D012293:Rifampin